{"schema_version":"secwatch.filing_event.v1","accession":"0001448431-25-000003","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2025-05-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.324699+00:00","generated_at":"2026-05-21T23:22:53.713005+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"OptimizeRx Q1 revenue up 11% to $21.9M; raises FY 2025 guidance","bullets":["Q1 revenue $21.9M (+11% YoY); gross profit $13.3M (+9% YoY).","GAAP net loss ($2.2M) or ($0.12)/share; non-GAAP net income $1.5M ($0.08)/diluted share.","Adjusted EBITDA $1.5M vs. ($0.3M) in prior-year Q1.","FY 2025 guidance raised: revenue $101M–$106M, adjusted EBITDA $13M–$15M.","Cash and investments $16.6M at March 31; net revenue retention 114%."],"urls":{"canonical":"https://secwatch.observer/filing/0001448431-25-000003","json":"https://secwatch.observer/filing/0001448431-25-000003.json","markdown":"https://secwatch.observer/filing/0001448431-25-000003.md","text":"https://secwatch.observer/filing/0001448431-25-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000144843125000003/0001448431-25-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000144843125000003/oprx-20250512.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T23:22:53.713005+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}